We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+17.41%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.17B
AUM Growth
+$204M
Cap. Flow
-$539M
Cap. Flow %
-10.44%
Top 10 Hldgs %
26.55%
Holding
192
New
25
Increased
43
Reduced
107
Closed
10

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$40.1M
2
PPLI
People Inc
PPLI
+$37.7M
3
ABBV icon
AbbVie
ABBV
+$37.7M
4
MTZ icon
MasTec
MTZ
+$30.4M
5
POOL icon
Pool Corp
POOL
+$23.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.37%
2 Healthcare 18.43%
3 Technology 14.97%
4 Financials 13.64%
5 Industrials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PS
151
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$5.71M 0.11%
+180,000
New +$5.33M
DQ
152
Daqo New Energy
DQ
$999M
$5.41M 0.1%
+819,275
New +$5.33M
ARQL
153
DELISTED
Arqule Inc
ARQL
$5.27M 0.1%
1,100,000
+100,000
+10% +$386K
GTES icon
154
Gates Industrial Corporation Ltd.
GTES
$7.02B
$4.73M 0.09%
+330,000
New +$4.98M
MRAM icon
155
Everspin Technologies
MRAM
$414M
$4.6M 0.09%
600,000
-25,000
-4% -$182K
SINA
156
DELISTED
Sina Corp
SINA
$4.59M 0.09%
77,500
STI
157
DELISTED
SunTrust Banks, Inc.
STI
$4.49M 0.09%
75,805
-226,000
-75% -$13.8M
TAL icon
158
TAL Education Group
TAL
$6.51B
$4.28M 0.08%
118,500
-44,600
-27% -$1.45M
WYNN icon
159
Wynn Resorts
WYNN
$10.6B
$3.9M 0.08%
32,700
-69,720
-68% -$8.33M
JOBS
160
DELISTED
51job Inc
JOBS
$3.89M 0.08%
50,000
-30,000
-38% -$2.08M
SRPT icon
161
Sarepta Therapeutics
SRPT
$1.94B
$3.16M 0.06%
26,500
MRTX
162
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.93M 0.06%
+40,000
New +$2.72M
MYOK
163
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.75M 0.05%
53,000
FOMX
164
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.55M 0.05%
680,000
+40,000
+6% +$150K
NKTR icon
165
Nektar Therapeutics
NKTR
$2.56B
$2.53M 0.05%
5,016
+747
+17% +$443K
COHR
166
DELISTED
Coherent Inc
COHR
$2.31M 0.04%
16,314
-39,713
-71% -$5.03M
YUMC icon
167
Yum China
YUMC
$16.4B
$2.25M 0.04%
50,000
+20,000
+67% +$788K
DMRC icon
168
Digimarc Corp
DMRC
$173M
$2.2M 0.04%
70,000
+20,000
+40% +$496K
NERV icon
169
Minerva Neurosciences
NERV
$189M
$2M 0.04%
31,875
+6,250
+24% +$376K
ITUB icon
170
Itaú Unibanco
ITUB
$82.3B
$1.51M 0.03%
235,979
-446,657
-65% -$3.16M
JOYY
171
JOYY Inc
JOYY
$3.75B
$1.07M 0.02%
12,700
-2,000
-14% -$145K
GRVY
172
GRAVITY
GRVY
$486M
$966K 0.02%
+15,000
New +$751K
SGMO
173
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$906K 0.02%
95,000
QIWI
174
DELISTED
QIWI PLC
QIWI
$720K 0.01%
50,000
+10,000
+25% +$146K
CLAR icon
175
Clarus
CLAR
$144M
$640K 0.01%
+50,222
New +$566K

Similar funds

Handelsbanken Fonder's Q1 2019 Portfolio in Review

As of Q1 2019, Handelsbanken Fonder held 192 positions worth $5.17B, up 4.1% from $4.96B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Handelsbanken Fonder withdrew a net $539M in Q1 2019, closing 10 positions and reducing 107 holdings. Its most notable exit was Cinemark Holdings, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Handelsbanken Fonder opened a new position in Boingo Wireless, Inc. worth $12.8M.

  • Handelsbanken Fonder's largest Q1 2019 buy was Boingo Wireless, Inc.: 550,000 shares worth $12.8M.
  • Handelsbanken Fonder added most to Eli Lilly in Q1 2019, an estimated $26.3M increase.
  • Handelsbanken Fonder's biggest Q1 2019 reduction was Johnson & Johnson, cutting an estimated $40.1M.
  • Handelsbanken Fonder fully exited Cinemark Holdings in Q1 2019, selling an estimated $20.4M.
  • Handelsbanken Fonder's ten largest holdings make up 27% of its $5.17B portfolio in Q1 2019.
  • Handelsbanken Fonder opened 25 new positions and closed 10 in Q1 2019.
  • Handelsbanken Fonder's portfolio value rose 4.1% quarter-over-quarter to $5.17B.

Based on Handelsbanken Fonder's 13F filing for Q1 2019, filed 10 May 2019.